142 related articles for article (PubMed ID: 28423533)
1. SPC24 is critical for anaplastic thyroid cancer progression.
Yin H; Meng T; Zhou L; Chen H; Song D
Oncotarget; 2017 Mar; 8(13):21884-21891. PubMed ID: 28423533
[TBL] [Abstract][Full Text] [Related]
2. HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.
Pan Z; Fang Q; Li L; Zhang Y; Xu T; Liu Y; Zheng X; Tan Z; Huang P; Ge M
Cancer Lett; 2021 Mar; 501():31-42. PubMed ID: 33359451
[TBL] [Abstract][Full Text] [Related]
3. SPC24 Regulates breast cancer progression by PI3K/AKT signaling.
Zhou J; Pei Y; Chen G; Cao C; Liu J; Ding C; Wang D; Sun L; Xu P; Niu G
Gene; 2018 Oct; 675():272-277. PubMed ID: 30180968
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo.
Zhang K; Yu M; Hao F; Dong A; Chen D
Cancer Biomark; 2016 Sep; 17(3):281-291. PubMed ID: 27802204
[TBL] [Abstract][Full Text] [Related]
5. FOXD3 regulates anaplastic thyroid cancer progression.
Yin H; Meng T; Zhou L; Zhao F; Li X; Li Y; Hu M; Chen H; Song D
Oncotarget; 2017 May; 8(20):33644-33651. PubMed ID: 28430585
[TBL] [Abstract][Full Text] [Related]
6. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
7. High expression of CD10 in anaplastic thyroid carcinomas.
Nakazawa T; Kondo T; Vuong HG; Odate T; Kawai M; Tahara I; Kasai K; Inoue T; Oishi N; Mochizuki K; Ito K; Katoh R
Histopathology; 2018 Sep; 73(3):492-499. PubMed ID: 29791034
[TBL] [Abstract][Full Text] [Related]
8. miR30a inhibits LOX expression and anaplastic thyroid cancer progression.
Boufraqech M; Nilubol N; Zhang L; Gara SK; Sadowski SM; Mehta A; He M; Davis S; Dreiling J; Copland JA; Smallridge RC; Quezado MM; Kebebew E
Cancer Res; 2015 Jan; 75(2):367-77. PubMed ID: 25488748
[TBL] [Abstract][Full Text] [Related]
9. Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma.
Zhao HD; Tang HL; Liu NN; Zhao YL; Liu QQ; Zhu XS; Jia LT; Gao CF; Yang AG; Li JT
Oncotarget; 2016 May; 7(21):31191-203. PubMed ID: 27145278
[TBL] [Abstract][Full Text] [Related]
10. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.
Saini S; Sripada L; Tulla K; Kumar P; Yue F; Kunda N; Maker AV; Prabhakar BS
Cell Death Dis; 2019 Feb; 10(2):145. PubMed ID: 30760700
[TBL] [Abstract][Full Text] [Related]
11. JAK/STAT3 and NF-κB Signaling Pathways Regulate Cancer Stem-Cell Properties in Anaplastic Thyroid Cancer Cells.
Shiraiwa K; Matsuse M; Nakazawa Y; Ogi T; Suzuki K; Saenko V; Xu S; Umezawa K; Yamashita S; Tsukamoto K; Mitsutake N
Thyroid; 2019 May; 29(5):674-682. PubMed ID: 30784360
[No Abstract] [Full Text] [Related]
12. Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target.
von Roemeling CA; Marlow LA; Pinkerton AB; Crist A; Miller J; Tun HW; Smallridge RC; Copland JA
J Clin Endocrinol Metab; 2015 May; 100(5):E697-709. PubMed ID: 25675381
[TBL] [Abstract][Full Text] [Related]
13. Role of pulmonary macrophages in initiation of lung metastasis in anaplastic thyroid cancer.
Li XJ; Gangadaran P; Kalimuthu S; Oh JM; Zhu L; Jeong SY; Lee SW; Lee J; Ahn BC
Int J Cancer; 2016 Dec; 139(11):2583-92. PubMed ID: 27537102
[TBL] [Abstract][Full Text] [Related]
14. Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.
Fourati A; El Amine O; Ben Ayoub W; Cherni I; Goucha A; El May MV; Gamoudi A; El May A
Bull Cancer; 2017 May; 104(5):433-441. PubMed ID: 28185633
[TBL] [Abstract][Full Text] [Related]
15. Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.
Jung CW; Han KH; Seol H; Park S; Koh JS; Lee SS; Kim MJ; Choi IJ; Myung JK
Int J Clin Exp Pathol; 2015; 8(1):560-8. PubMed ID: 25755746
[TBL] [Abstract][Full Text] [Related]
16. Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells
Jo S; Ha TK; Han SH; Kim ME; Jung I; Lee HW; Bae SK; Lee JS
Anticancer Res; 2017 Apr; 37(4):1705-1710. PubMed ID: 28373432
[TBL] [Abstract][Full Text] [Related]
17. A potential prognostic biomarker SPC24 promotes tumorigenesis and metastasis in lung cancer.
Zhou J; Yu Y; Pei Y; Cao C; Ding C; Wang D; Sun L; Niu G
Oncotarget; 2017 Sep; 8(39):65469-65480. PubMed ID: 29029446
[TBL] [Abstract][Full Text] [Related]
18. Generation of Novel Thyroid Cancer Stem-Like Cell Clones: Effects of Resveratrol and Valproic Acid.
Hardin H; Yu XM; Harrison AD; Larrain C; Zhang R; Chen J; Chen H; Lloyd RV
Am J Pathol; 2016 Jun; 186(6):1662-73. PubMed ID: 27060227
[TBL] [Abstract][Full Text] [Related]
19. Search for new genetic biomarkers in poorly differentiated and anaplastic thyroid carcinomas using next generation sequencing.
Sykorova V; Dvorakova S; Vcelak J; Vaclavikova E; Halkova T; Kodetova D; Lastuvka P; Betka J; Vlcek P; Reboun M; Katra R; Bendlova B
Anticancer Res; 2015 Apr; 35(4):2029-36. PubMed ID: 25862857
[TBL] [Abstract][Full Text] [Related]
20. Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations.
Smith N; Nucera C
J Clin Endocrinol Metab; 2015 Jan; 100(1):35-42. PubMed ID: 25347569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
